Ad is loading...
DNLI
Price
$25.05
Change
-$3.40 (-11.95%)
Updated
Nov 15 closing price
105 days until earnings call
STOK
Price
$12.03
Change
-$1.89 (-13.58%)
Updated
Nov 15 closing price
108 days until earnings call
Ad is loading...

DNLI vs STOK

Header iconDNLI vs STOK Comparison
Open Charts DNLI vs STOKBanner chart's image
Denali Therapeutics
Price$25.05
Change-$3.40 (-11.95%)
Volume$1.1M
CapitalizationN/A
Stoke Therapeutics
Price$12.03
Change-$1.89 (-13.58%)
Volume$813.82K
CapitalizationN/A
DNLI vs STOK Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNLI vs. STOK commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Sell and STOK is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (DNLI: $25.05 vs. STOK: $12.03)
Brand notoriety: DNLI and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 126% vs. STOK: 138%
Market capitalization -- DNLI: $3.61B vs. STOK: $637.19M
DNLI [@Biotechnology] is valued at $3.61B. STOK’s [@Biotechnology] market capitalization is $637.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • STOK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both DNLI and STOK are a bad buy in the short-term.

Price Growth

DNLI (@Biotechnology) experienced а -20.10% price change this week, while STOK (@Biotechnology) price change was -13.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

STOK is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.61B) has a higher market cap than STOK($637M). STOK YTD gains are higher at: 128.707 vs. DNLI (16.729). STOK has higher annual earnings (EBITDA): -112.16M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. STOK (282M). STOK has less debt than DNLI: STOK (2.28M) vs DNLI (48.8M). STOK has higher revenues than DNLI: STOK (15.2M) vs DNLI (1.27M).
DNLISTOKDNLI / STOK
Capitalization3.61B637M566%
EBITDA-486.71M-112.16M434%
Gain YTD16.729128.70713%
P/E RatioN/AN/A-
Revenue1.27M15.2M8%
Total Cash896M282M318%
Total Debt48.8M2.28M2,143%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLISTOK
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NAIGX28.23-0.04
-0.14%
Nuveen International Value A
GRHAX13.35-0.10
-0.74%
Goehring & Rozencwajg Resources Retail
CISMX14.64-0.13
-0.88%
Clarkston Partners Institutional
AWSHX64.27-0.73
-1.12%
American Funds Washington Mutual A
WTRCX13.89-0.19
-1.35%
Delaware Ivy Core Equity Fund Class C

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-11.95%
BEAM - DNLI
63%
Loosely correlated
-8.59%
ALEC - DNLI
59%
Loosely correlated
-17.21%
NTLA - DNLI
56%
Loosely correlated
-7.61%
JANX - DNLI
55%
Loosely correlated
-4.58%
RCKT - DNLI
54%
Loosely correlated
-5.67%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-13.58%
NUVB - STOK
52%
Loosely correlated
-8.36%
QTTB - STOK
48%
Loosely correlated
-7.52%
STRO - STOK
47%
Loosely correlated
-16.23%
INZY - STOK
43%
Loosely correlated
-8.89%
DNLI - STOK
42%
Loosely correlated
-11.95%
More